GGrantIndex
← Leaderboards

Kenneth B. Schechtman

Washington University

Google Scholar ↗PubMed ↗ORCID ↗
$8,169,265
Attributed
$32,113,767
Total exposure
11
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6.5M · FY2010–25
$10M$7.5M$5M$2.5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$32,113,767 · 11

By mechanism

R01$15,944,357 · 1
U24$9,471,643 · 1
R33$2,186,803 · 1
R34$1,607,924 · 3
P30$996,436 · 1
R61$803,813 · 1

Top collaborators

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Protocols Documentation”

Research focus

Protocols DocumentationDesignRandomizedGrantMeasurementProceduresManualsSiteCaringUniversitiesQuestionnairesPublic HealthReportingMonitorMortalityResearch DesignResearch PersonnelHuman ResourcesEnrollmentImpairmentPlacebosAdherenceBiometryDouble-Blind Method

Grant awards (39)

The Inorganic Nitrate and eXercise performance in Heart Failure (iNIX-HF): - a phase II clinical trial$708,812
R33 · FY2025 · HL
Implementation Research Strategies for Heart, Lung, and Blood Co-morbidities in People Living with HIV - Research Coordinating Center$1,390,898
U24 · FY2024 · HL · contact PI
The Inorganic Nitrate and eXercise performance in Heart Failure (iNIX-HF): - a phase II clinical trial$740,803
R33 · FY2024 · HL
Implementation Research Strategies for Heart, Lung, and Blood Co-morbidities in People Living with HIV - Research Coordinating Center$1,914,241
U24 · FY2023 · HL · contact PI
Combining Testosterone Therapy and Exercise to Improve Function Post Hip Fracture$1,851,883
R01 · FY2023 · AG
The Inorganic Nitrate and eXercise performance in Heart Failure (iNIX-HF): - a phase II clinical trial$737,188
R33 · FY2023 · HL
Combining Testosterone Therapy and Exercise to Improve Function Post Hip Fracture$3,021,234
R01 · FY2022 · AG
Implementation Research Strategies for Heart, Lung, and Blood Co-morbidities in People Living with HIV - Research Coordinating Center$1,914,241
U24 · FY2022 · HL · contact PI
The Inorganic Nitrate and eXercise performance in Heart Failure (iNIX-HF): - a phase II clinical trial$803,813
R61 · FY2022 · HL
Supplement: Implementation Research Strategies for Heart, Lung, and Blood Co-morbidities in People Living with HIV - Research Coordinating Center$752,070
U24 · FY2022 · HL · contact PI
Implementation Research Strategies for Heart, Lung, and Blood Co-morbidities in People Living with HIV - Research Coordinating Center$1,990,173
U24 · FY2021 · HL · contact PI
Implementation Research Strategies for Heart, Lung, and Blood Co-morbidities in People Living with HIV - Research Coordinating Center$1,510,020
U24 · FY2020 · HL · contact PI
A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression in Lung Transplantation$237,979
R34 · FY2020 · HL
THE EFFECTIVENESS OF FAMILY-BASED WEIGHT LOSS TREATMENT IMPLEMENTED IN PRIMARY CARE - DCC$118,679
U01 · FY2020 · HL · contact PI
Combining Testosterone Therapy and Exercise to Improve Function Post Hip Fracture$4,129,857
R01 · FY2019 · AG
A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression in Lung Transplantation$237,524
R34 · FY2019 · HL
THE INORGANIC NITRATE FOR EXERCISE IN HEART FAILURE (INIX-HF) TRIAL$229,250
R34 · FY2019 · HL
THE EFFECTIVENESS OF FAMILY-BASED WEIGHT LOSS TREATMENT IMPLEMENTED IN PRIMARY CARE - DCC$138,642
U01 · FY2019 · HL · contact PI
Combining Testosterone Therapy and Exercise to Improve Function Post Hip Fracture$80,522
R01 · FY2019 · AG
Combining Testosterone Therapy and Exercise to Improve Function Post Hip Fracture$4,142,501
R01 · FY2018 · AG
A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression in Lung Transplantation$250,034
R34 · FY2018 · HL
THE INORGANIC NITRATE FOR EXERCISE IN HEART FAILURE (INIX-HF) TRIAL$234,106
R34 · FY2018 · HL
THE EFFECTIVENESS OF FAMILY-BASED WEIGHT LOSS TREATMENT IMPLEMENTED IN PRIMARY CARE - DCC$138,924
U01 · FY2018 · HL · contact PI
Combining Testosterone Therapy and Exercise to Improve Function Post Hip Fracture$21,353
R01 · FY2018 · AG
Combining Testosterone Therapy and Exercise to Improve Function Post Hip Fracture$2,697,007
R01 · FY2017 · AG
THE INORGANIC NITRATE FOR EXERCISE IN HEART FAILURE (INIX-HF) TRIAL$237,519
R34 · FY2017 · HL
MASSIVE TRANSFUSION EPIDEMIOLOGY AND OUTCOMES IN CHILDREN (MATIC) STUDY$235,875
R21 · FY2017 · HL
THE EFFECTIVENESS OF FAMILY-BASED WEIGHT LOSS TREATMENT IMPLEMENTED IN PRIMARY CARE - DCC$139,223
U01 · FY2017 · HL · contact PI
MASSIVE TRANSFUSION EPIDEMIOLOGY AND OUTCOMES IN CHILDREN (MATIC) STUDY$197,750
R21 · FY2016 · HL
THE EFFECTIVENESS OF FAMILY-BASED WEIGHT LOSS TREATMENT IMPLEMENTED IN PRIMARY CARE - DCC$133,698
U01 · FY2016 · HL · contact PI
Biostatistics and Informatics Core$190,003
P30 · FY2014 · HD · contact PI
Biostatistics and Informatics Core$187,531
P30 · FY2013 · HD · contact PI
COMBINING TESTOSTERONE THERAPY AND EXERCISE TO IMPROVE FUNCTION POST HIP FRACTURE$181,512
R34 · FY2013 · AG
Biostatistics and Informatics Core$200,421
P30 · FY2012 · HD · contact PI
Biostatistics and Informatics Core$208,157
P30 · FY2011 · HD · contact PI
Biostatistics and Informatics Core$210,324
P30 · FY2010 · HD · contact PI
Genetic, biologic and immunologic determinants of asthma$0
M01 · FY2002 · RR
Genetic, biologic and immunologic determinants of asthma$0
M01 · FY2001 · RR
Genetic, biologic and immunologic determinants of asthma$0
M01 · FY2000 · RR